Test: | AFB Mycobacterium tuberculosis Amplified Direct Detection Supplemental Forms Required – Mycobacterium tuberculosis (MTB) Supplemental |
Synonym: | TBAPR, TB PCR, Qualitative Real Time PCR, TB NAAT |
Method: | Cepheid GeneXpert MTB Assay to detect Mycobacterium tuberculosis (MTB) complex directly from sputum |
Availability: | Monday - Friday by 0800. STAT testing is not indicated and should not be performed. If for isolation release protocol, two sputum specimens may be tested per patient, but must be collected at least 8 hours apart. |
Specimen: | Early morning Sputum (expectorated or induced). Source of specimen indicated on requisition is required. MTB testing must be accompanied by an Acid Fast Bacilli Culture order (AFBCU). Routinely, only one specimen per patient will be tested (If for isolation release protocol, 2 specimens may be tested, but must be at least 8 hours apart.) Positive AFB smears on first time AFB positive patients will be automatically reflexed for testing. Please note on test request form if sputum from a Cystic Fibrosis patient |
Collection Device: | Sputum in a sterile leak-proof container. Gastric aspirate, body fluid and tissue in a sterile leak-proof container. Store and transport refrigerated at 2-8°C. Specimen Labeling: Test subject to CLIA regulations and required 2 patient identifiers on specimen container and requisition forms |
Volume: | 5-20 ml sputum |
Storage/Transport: | Prior to and during shipment: Refrigerated at 2-8 °C. Place each individual specimen in a sealed bag. Shipping instructions, including specimen-handling requirements during transport: |
Unacceptable: | Bloody specimens, leaking containers, Non sputum specimen. Swabs. Specimens with food or solid particles. |
Specimen Stability: | Refrigerate 2-8°C up to 7 days |
Reference Interval: | Negative A negative result does not exclude M. tuberculosis complex infection. |
Reportable Disease: | MTB complex will be reported immediately to local or state health department. Refer to Nebraska DHHS Title 173, Communicable Diseases |
Comments: | This test utilizes quantitative real time PCR technology that can be used on either acid fast bacilli (AFB) smear positive specimens or AFB smear negative specimens. Based on CDC recommendations, the test is appropriate for patients showing symptoms of active pulmonary tuberculosis and for whom the test result would alter case management or TB control activities. A specimen with a first time AFB positive smear on a suspect tuberculosis patient will also be automatically reflexed for Mycobacterium TB Amplified Direct Testing. Only one specimen per patient will be tested. Order in NUlirt |
Revised: | 9/2/2020 |